U.S. markets open in 1 hour 49 minutes

Achieve Life Sciences, Inc. (ACHV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
11.08-0.32 (-2.81%)
At close: 4:00PM EDT

Achieve Life Sciences, Inc.

1040 West Georgia Street
Suite 1030
Vancouver, BC V6E 4H1
Canada
604 210 2217
http://www.achievelifesciences.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees13

Key Executives

NameTitlePayExercisedYear Born
Dr. Richard A. B. StewartExec. Chairman699.48kN/A1959
Mr. John A. BencichCEO & Director620.52kN/A1977
Dr. Cindy JacobsPres, Chief Medical Officer & Director579.81kN/A1958
Mr. Jerry WanSr. Director of Accounting Operations & Principal Accounting OfficerN/AN/AN/A
Dr. Anthony ClarkChief Scientific OfficerN/AN/A1956
Ms. Jaime XinosExec. VP of CommercialN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

Corporate Governance

Achieve Life Sciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.